Cosmeceuticals: Products and Global Markets

NEW YORK, Aug. 12, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cosmeceuticals: Products and Global Markets
http://www.reportlinker.com/p01595222/Cosmeceuticals-Products-and-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biomaterial

This study presents a comprehensive view of the recent trends in the global cosmeceutical industry and includes the projections for global and regional sales of cosmeceuticals through 2017.

Use this report to:

- Evaluate industry structure, including distinctive regional differences in R&D, marketing, and regulatory requirements.
- Learn about the recent patents awarded for cosmeceuticals by type.
- Explore present and future strategies within the global market for all products based on cosmeceuticals.
- Comprehensive company profiles of major players in the industry.

Highlights

- Global sales of topical and injectable cosmeceutical products amounted to nearly $31.7 billion in 2011. It is projected to reach nearly $45.6 billion in 2017 from $35 billion in 2012, representing a five-year compound annual growth rate (CAGR) of 5.4% between 2012 and 2017.
- Sales of topical cosmeceuticals amounted to nearly $33.4 billion in 2012, and are projected to increase to almost $42.8 billion in 2017, representing a CAGR of 5.1%.
- Injectable cosmeceuticals market sales amounted to $1.6 billion in 2012. The global sales of injectable cosmeceutical products are projected to increase at a CAGR of 11.8% between 2012 and 2017, and reach over $2.8 billion in 2017.

STUDY GOALS AND OBJECTIVES

BCC conducted this study to present a comprehensive view of the recent trends in the global cosmeceutical industry and to develop market projections through 2017. One goal was to identify global demand patterns, regional distinctions and key factors that shaped recent historical market size and shares. Another goal was to explore future developments, challenges and opportunities in the highly dynamic and competitive cosmeceutical industry. The study documents the importance of product innovation and differentiation, agile market strategies, nuanced government regulatory oversight and fluid consumer expectations in the global cosmeceutical industry.

REASONS FOR DOING THIS STUDY

As one of the fastest-growing segments of the global toilet preparation and cosmetic industry, it is important for stakeholders to have a reliable information framework to manage business decisions. While there is a lot that is confusing in the current state of the industry, there is ample evidence that many people see strong activity over the foreseeable future, fueled by exceptional consumer demand. The scientific community has more than a casual interest in cosmeceuticals because the secret is out that companies that want to keep up with evolving industry trends need to have superior scientific backup. Premium products that dominate the market are often the outcome of years of extensive research, proprietary technologies, testing and documentation.
Even a cursory look at the product labels shows the role of science in the choice of ingredients and formulary. Increasingly, the mass market is benefiting from the sophistication of the prestige segment, creating a blurring of the lines in some product maintain beneficial competitive advantage.

SCOPE OF REPORT

This report covers recent developments in the global market for cosmeceuticals. A detailed list of commonly used natural and synthetic ingredients provides a background for the presentation of the topical and injectable cosmeceutical products currently available and those that are likely to be introduced in the near future. The study focuses on cosmeceutical products that promise antiaging and overall appearance-enhancing benefits for adults 18 years and over.
At the date of this report, there is no official classification for cosmeceuticals in most countries. These products are essentially a subset of the cosmetics (skin care) segment of the beauty and personal care industry. The structure of the industry, including distinctive regional differences in R&D, marketing and government regulatory requirements are discussed.
Details of recent sales, market drivers and drawbacks, technological advances and patents inform the projections of global and regional sales of cosmeceuticals through 2017. For the purpose of this report, the regional markets are classified as Asia-Pacific, Europe, North America and the rest of the world (ROW). Profiles of major manufacturers of cosmeceuticals are presented in the report.

INTENDED AUDIENCE

This report put together, in one place, valuable and current information about the fast-evolving cosmeceutical industry. Historical data and market projections through 2017 provide a comprehensive context for assessing challenges and opportunities in the industry. Companies already engaged in the cosmeceutical business and those seeking areas of expansion will find the information presented in this report useful for their decision-making. This study will be a resource for anyone interested in understanding some of the fundamentals of the manufacture and marketing of cosmeceuticals in the global arena.

METHODOLOGY AND INFORMATION SOURCES

This report is the result of extensive research of primary and secondary informations sources. BCC surveyed relevant databases from the U.S. and foreign governments as well as international organizations. Information from highly acclaimed industry publications and databanks maintained by the financial/investment community is used
for validating the qualitative and quantitative analytical framework used to develop the findings presented in this report. Communications with various industry experts provide supplemental information on various aspects of the study.

CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THIS STUDY 2
SCOPE OF REPORT 2
INTENDED AUDIENCE 3
METHODOLOGY AND

INFORMATION SOURCES
3
ANALYST'S CREDENTIALS 3
RELATED BCC REPORTS 3
BCC ONLINE SERVICES 4
DISCLAIMER 4
CHAPTER 2 SUMMARY 6
SUMMARY TABLE GLOBAL SALES OF TOPICAL AND INJECTABLE COSMECEUTICALS,
THROUGH 2017 ($ MILLIONS) 6
SUMMARY FIGURE PROJECTED SHARES OF GLOBAL COSMECEUTICAL SALES BY
TYPE, 2012 AND 2017 (%) 6
CHAPTER 3 OVERVIEW 9
BACKGROUND 9
INDUSTRY CONCEPTS 10
SKIN STRUCTURE 10
SKIN AGING 10
SKIN DAMAGE 11
SKIN SENSITIVITY 12
HYPERPIGMENTATION 12
IMPORTANCE OF COSMECEUTICALS 12
FORESEEABLE DEVELOPMENTS 13
CHAPTER 4 INDUSTRY CHARACTERISTICS AND REGULATION 15
INTRODUCTION 15
CHARACTERISTICS OF THE GLOBAL COSMECEUTICAL INDUSTRY 15
SNAPSHOT OF THE COSMETICS INDUSTRY 15
TABLE 1 BUSINESS PATTERN OF U.S. TOILET PREPARATION AND MANUFACTURING
INDUSTRY (NO./%) 16
HIGHLY COMPETITIVE 16
PERVASIVE PRODUCT DIFFERENTIATION 17
DISTRIBUTION CHANNELS 17
PRODUCT ADVERTISING 17
REGULATORY GUIDELINES FOR THE COSMECEUTICAL INDUSTRY 18
REGULATORY GUIDELINES IN NORTH AMERICA 18
COSMETIC GUIDELINES IN THE U.S. 18
Responsible Regulatory Agency for Cosmetics in the U.S. 18
Regulations Governing Cosmetics in the U.S. 19
Definition of Cosmetics in the U.S. 19
Ingredients Restricted and Prohibited in Cosmetics Sold in the U.S. 19
TABLE 2 INGREDIENTS BANNED FROM COSMETICS SOLD IN THE U.S. 20
Regulation of Cosmetic Product Labeling 20
Definition of Adulterated Cosmetics 21
U.S. Recall Policy for Cosmetics 22
Regulatory Action for Drug Claims Made for Products Marketed as
Cosmetics 22
Regulation of Cosmetics Imports 23
Nanotechnology and Cosmetics 23
Advertising Cosmetics in the U.S. 24
General Considerations on Product Endorsements in the U.S. 24
Standards for Expert Endorsements in the U.S. 24
The Case of Blog Advertising Service 25
COSMETICS GUIDELINES IN CANADA 26
Responsible Regulatory Agency for Cosmetics in Canada 26
Mandatory Notification of Cosmetic Products 26
Safety of Cosmetic Products and Ingredients: Cosmetic Ingredient
Hotlist 27
Labeling of Cosmetic Products 27
Cosmetic Product Advertisement and Claims 27
TABLE 3 EXAMPLES OF ACCEPTABLE AND UNACCEPTABLE CLAIMS FOR CONTOUR
CREAMS IN CANADA 28
TABLE 4 EXAMPLES OF ACCEPTABLE AND UNACCEPTABLE CLAIMS FOR
EXFOLIANTS IN CANADA 28
TABLE 5 EXAMPLES OF ACCEPTABLE AND UNACCEPTABLE CLAIMS FOR
MOISTURIZERS IN CANADA 29
TABLE 6 EXAMPLES OF ACCEPTABLE AND UNACCEPTABLE CLAIMS FOR VITAMINS,
MINERALS AND ANTIOXIDANTS IN CANADA 29
REGULATORY GUIDELINES IN EUROPE 30
THE LATEST (NEW) COSMETIC PRODUCTS REGULATION IN THE EU 30
EU DEFINITION OF COSMETIC PRODUCTS 30
EU REGULATION REGARDING PRODUCT NOTIFICATION 31
EU REGULATION REGARDING NANOMATERIALS IN COSMETICS 32
LONG LISTS OF RESTRICTED AND PROHIBITED INGREDIENTS IN THE EU 32
MONITORING OF COUNTERFEIT COSMETIC PRODUCTS IN THE EU 33
FORTHCOMING EU REGULATION ON PRODUCT CLAIMS 33
REGULATORY GUIDELINES IN ASIA-PACIFIC 33
COSMETICS GUIDELINES IN JAPAN 33
Regulation of Cosmetics in Japan 34
Definition of Cosmetics in Japan 34
Standards for Cosmetics in Japan 35
COSMETICS GUIDELINES IN CHINA 35
Responsible Regulatory Agency for Cosmetics in China 35
Legislations Governing Cosmetics in China 36
TABLE 7 REGULATIONS RELATING TO COSMETICS IN CHINA 36
Definition and Classification of Cosmetics in China 36
Determination of Whether an Ingredient is New in China 37
Registration of New Cosmetic Ingredients in China 38
Cosmetic Labeling Requirements in China 38
Exporting Cosmetics to China 39
China Inspection and Quarantine (CIQ) Bureau Inspection of Imported
Cosmetics 39
COSMETICS GUIDELINES IN SOUTH KOREA 40
Responsible Regulatory Agency for Cosmetics in Korea 40
Definition of Cosmetics in Korea 40
Regulations of Cosmetics Imports to Korea 40
Revised Korea Cosmetics Act 41
COSMETICS GUIDELINES IN AUSTRALIA 42
Responsible Regulatory Agency for Cosmetics in Australia 42
Definition of Cosmetics in Australia 42
Product-Specific Requirements in Australia 42
TABLE 8 PRODUCT-SPECIFIC REGULATIONS IN AUSTRALIA 43
Australia's Regulation on Cosmetic Product Labeling 43
Regulation of Cosmetic Existing and New Ingredients in Australia 44
FUTURE OF REGULATORY ENVIRONMENT IN THE GLOBAL COSMETICS
INDUSTRY 44
CHAPTER 5 THE GLOBAL MARKET FOR TOPICAL COSMECEUTICALS 47
BACKGROUND 47
CATEGORIES OF TOPICAL COSMECEUTICAL INGREDIENTS 47
Antioxidants 47
TABLE 9 EXAMPLES OF ANTIOXIDANTS USED IN COSMECEUTICALS 48
Antibacterial Agents 48
TABLE 10 TYPES OF ANTIBACTERIAL AGENTS USED IN COSMECEUTICALS 49
Anti-inflammatory Agents 49
Barrier-enhancing Agents 49
Botanicals 50
TABLE 11 EXAMPLES OF BOTANICALS USED IN COSMECEUTICALS 50
Depigmenting Agents 50
TABLE 12 EXAMPLES OF DEPIGMENTING AGENTS USED IN COSMECEUTICALS 51
Enzymes 51
TABLE 13 EXAMPLES OF ENZYMES USED IN COSMECEUTICALS 52
Hydroxy Acids 52
TABLE 14 EXAMPLES OF HYDROXY ACIDS USED IN COSMECEUTICALS 53
Marine Actives 53
Moisturizers 54
TABLE 15 EXAMPLES OF MOISTURIZERS USED IN COSMECEUTICALS 54
Peptides 54
TABLE 16 TYPES OF PEPTIDES USED IN COSMECEUTICALS 55
Retinoids 55
Sunscreens 55
TOPICAL COSMECEUTICALS BY FUNCTION 57
SAMPLES OF TOPICAL COSMECEUTICALS BY FUNCTION 57
TABLE 17 SAMPLE OF TOPICAL ANTIAGING COSMECEUTICALS 57
TABLE 18 SAMPLE OF TOPICAL DEPIGMENTING COSMECEUTICALS 58
TABLE 19 SAMPLE OF TOPICAL APPEARANCE-ENHANCING COSMECEUTICALS 58
SPECIALTY/SPA BRANDS OF TOPICAL COSMECEUTICALS 59
Ahava and the Dead Sea Minerals 59
TABLE 20 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM AHAVA 60
Clarins 60
TABLE 21 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM CLARINS 60
Dermalogica 61
TABLE 22 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM DERMALOGICA 61
Garnier 61
TABLE 23 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM GARNIER 62
Jane Iredale 62
TABLE 24 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM JANE IREDALE 63
Obagi Medical Products 63
TABLE 25 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM OBAGI MEDICAL
PRODUCTS 64
Origins 64
TABLE 26 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM ORIGINS 64
PCA Skin Care 65
TABLE 27 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM PCA SKIN CARE 65
SkinCeuticals 65
TABLE 28 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM SKINCEUTICALS 66
StriVectin 66
TABLE 29 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM STRIVECTIN 67

RECENT GLOBAL SALES OF TOPICAL COSMECEUTICALS 67
INDUSTRY DATA 67
RECENT GLOBAL SALES OF TOPICAL COSMECEUTICALS BY PRODUCT
FUNCTION 68
TABLE 30 GLOBAL SALES OF TOPICAL COSMECEUTICALS BY PRODUCT FUNCTION,
2011 ($ MILLIONS, %) 68
Recent Global Sales of Antiaging Topical Cosmeceuticals 68
Recent Global Sales of Appearance-enhancing Topical
Cosmeceuticals 69
FIGURE 1 ESTIMATED MARKET SHARES OF GLOBAL SALES OF TOPICAL
COSMECEUTICALS BY PRODUCT FUNCTION, 2011 (%) 69
Regional Shares of Recent Global Sales of Topical Cosmeceuticals 70
FIGURE 2 ESTIMATED MARKET SHARES OF GLOBAL SALES OF TOPICAL
COSMECEUTICALS BY REGION, 2011 (%) 70
MAJOR MANUFACTURERS OF TOPICAL COSMECEUTICALS 71
TABLE 31 ADDITION MAJOR MANUFACTURERS OF TOPICAL COSMECEUTICALS 71
TABLE 32 MANUFACTURERS OF SPECIALTY TOPICAL COSMECEUTICALS 71
PROJECTED GLOBAL SALES OF TOPICAL COSMECEUTICALS 72
MARKET DRIVERS AND DRAWBACKS 72
Demographic Trends 72
Science-based Targeted Product Formulations 72
Preparations Targeting Acne 73
Products Targeting Rosacea 73
BB/CC Creams and Other Multifunctional Products 73
Stricter Regulatory Oversight 74
SALES AND MARKET SIZE PROJECTIONS 75
PROJECTED GLOBAL SALES OF TOPICAL COSMECEUTICALS 76
Total Global Sales of Topical Cosmeceuticals Through 2017 76
TABLE 33 GLOBAL SALES OF TOPICAL COSMECEUTICALS BY PRODUCT FUNCTION,
THROUGH 2017 ($ MILLIONS) 76
FIGURE 3 ESTIMATED SHARES OF GLOBAL TOPICAL COSMECEUTICAL SALES BY
PRODUCT FUNCTION, 2012 AND 2017 (%) 76
Projected Global Sales of Topical Cosmeceuticals by Region Through
2017 77

TABLE 34 GLOBAL SALES OF TOPICAL COSMECEUTICALS BY REGION, THROUGH
2017 ($ MILLIONS) 78
FIGURE 4 ESTIMATED SHARES OF GLOBAL TOPICAL COSMECEUTICAL SALES BY
REGION, 2012 AND 2017 (%) 78
Projected Global Sales of Antiaging Cosmeceuticals by Region
Through 2017 79
TABLE 35 GLOBAL SALES OF ANTIAGING TOPICAL COSMECEUTICALS BY REGION,
THROUGH 2017 ($ MILLIONS) 79
FIGURE 5 ESTIMATED SHARES OF GLOBAL ANTIAGING TOPICAL COSMECEUTICAL
SALES BY REGION, 2012 AND 2017 (%) 80
Projected Global Sales of Appearance-enhancing Cosmeceuticals by
Region Through 2017 80
TABLE 36 GLOBAL SALES OF APPEARANCE-ENHANCING TOPICAL COSMECEUTICALS
BY REGION, THROUGH 2017 ($ MILLIONS) 81
FIGURE 6 ESTIMATED SHARES OF GLOBAL APPEARANCE TOPICAL COSMECEUTICAL
SALES BY REGION, 2012 AND 2017 (%) 81
CHAPTER 6 THE GLOBAL MARKET FOR INJECTABLE COSMECEUTICALS 84
INDUSTRY OVERVIEW 84
CURRENT U.S. FDA REGULATION ON BOTULINUM TOXIN (BOTOX) 84
TABLE 37 U.S. FDA-APPROVED BOTULINUM TOXIN FOR COSMETIC USE 85
INJECTABLE COSMECEUTICALS BY TYPE 85
BOTOX COSMETIC-THE CURRENT GOLD STANDARD FOR INJECTABLES 85
DYSPORT 86

DERMAL FILLERS-BOTOX ALTERNATIVES (A.K.A. FACIAL AESTHETICS) 87
Types of Dermal Fillers 87
Examples of Commonly Used Dermal Fillers 87
ArteFill Dermal Filler 87
Juvederm 88
Radiesse 88
Restylane 89
RECENT GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY TYPE 89
INDUSTRY DATA 89
RECENT GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY TYPE 90
TABLE 38 GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY TYPE, 2011 ($
MILLIONS/%) 90
Recent Global Sales of Botox-type Cosmeceuticals 90
Recent Global Sales of Dermal Fillers 91
FIGURE 7 GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY TYPE, 2011 (%) 91
Regional Shares of Recent Global Sales of Injectable Cosmeceuticals 91
FIGURE 8 ESTIMATED MARKET SHARES OF GLOBAL SALES OF INJECTABLE
COSMECEUTICALS BY REGION, 2011 (%) 92
MAJOR MANUFACTURERS OF INJECTABLE COSMECEUTICALS 92
TABLE 39 MAJOR MANUFACTURERS OF INJECTABLE COSMECEUTICALS 93
PROJECTED GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY TYPE 93
MARKET DRIVERS AND DRAWBACKS 93
Future Competition to Botox-type Cosmetics 93
Consumer Preferences and Demand 93
Ongoing Regulatory Oversight 94
SALES AND MARKET SIZE PROJECTIONS 94
PROJECTED GLOBAL SALES OF INJECTABLE COSMECEUTICALS 94
Total Global Sales of Injectable Cosmeceuticals Through 2017 94
TABLE 40 GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY TYPE, THROUGH
2017 ($ MILLIONS) 95
FIGURE 9 ESTIMATED SHARES OF GLOBAL INJECTABLE COSMECEUTICAL SALES BY
TYPE, 2012 AND 2017 (%) 95
Projected Global Sales of Injectable Cosmeceuticals by Region
Through 2017 96
TABLE 41 GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY REGION, THROUGH
2017 ($ MILLIONS) 96
FIGURE 10 ESTIMATED SHARES OF GLOBAL INJECTABLE COSMECEUTICAL SALES
BY REGION, 2012 AND 2017 (%) 96
Projected Global Sales of Botox-type Cosmeceuticals by Region
Through 2017 97
TABLE 42 GLOBAL SALES OF BOTOX-TYPE COSMETICS BY REGION, THROUGH 2017
($ MILLIONS) 98
FIGURE 11 ESTIMATED SHARES OF GLOBAL BOTOX-TYPE COSMETIC SALES BY
REGION, 2012 AND 2017 (%) 98
Projected Global Sales of Dermal Fillers by Region Through 2017 99
TABLE 43 GLOBAL SALES OF DERMAL FILLERS BY REGION, THROUGH 2017 ($
MILLIONS) 99
FIGURE 12 ESTIMATED SHARES OF GLOBAL DERMAL FILLER SALES BY REGION,
2012 AND 2017 (%) 99
CHAPTER 7 TECHNOLOGY AND PATENT ANALYSIS 102
INTRODUCTION 102
COSMETIC DELIVERY METHODS 102
DELCORE DELIVERY SYSTEM FROM CONTIPRO BIOTECH 102
MICROSPONGE DELIVERY SYSTEMS FROM AMCOL 102
Poly-Pore Technology 103

Polytrap Technology 103
MOLECULAR FILM DELIVERY SYSTEMS FROM CENTERCHEM 103
Intelimer 8600 Emulsion Polymer 104
Retinol Molecular Film Fluid 104
NANOTECHNOLOGY IN COSMETICS 104
PATENT ANALYSIS 105
TABLE 44 U.S. PATENTS AWARDED FOR COSMECEUTICAL INGREDIENTS BY TYPE,
2011–2012 (NO./%) 105
TABLE 45 U.S. PATENTS AWARDED FOR COSMECEUTICAL INGREDIENTS BY REGION,
2011–2012 (NO./%) 106
PATENTS RELATING TO ANTIOXIDANTS 106
Sample of Patents Relating to Antioxidants 106
Ampholytic Copolymer Based on Quaternized
Nitrogen-containing Monomers 106
Cosmetic Composition Comprising an Aqueous Extract of
Chrysophyllum cainito 107
Pawpaw and Peach Derived Composition 108
Liquid Concentrate for Preserving Cosmetics 108
Cosmetic Use of an Active Agent Capable of Stimulating Tensin
1 Expression 109
7-hydroxy Chromones as Potent Antioxidants 109
PATENTS RELATING TO BOTANICALS 110
Sample of Patents Relating to Botanicals 110
Composition and Method of Preparing a Tomato-based Topical
Formulation for Enhanced Healing of Burns, Ultraviolet and
Radiation Erythema

110
Compositions of Marine Botanicals to Provide Nutrition to Aging
and Environmentally Damaged Skin 111
Hydrocarbon Mixture and Use Thereof 111
Use of a Brassocattleya marcella Koss Orchid Extract as an
Active Agent to Prevent or Delay the Appearance of Signs of
Cutaneous Aging
112
Topical Skin Formulations Comprising Plant Extracts 112
Non-therapeutic Methods of Evaluating Skin Neurosensitivity, Kit
and Use of a Kit for Implementing the Method 113
Emulsion Cosmetic Compositions Containing Resveratrol
Derivatives and Linear or Branched Silicone 113
Modified Green Tea Polyphenol Formulations 114
Topical Compositions for Antiaging and Methods of Using Same 115
Self-adhesive Polymer Matrix Containing Sea Algae Extract 115
Modified Variant Bowman Birk Protease Inhibitors 116
Hand and Body Cream 116
PATENTS RELATING TO BOTOX 117
Sample of Patents Relating to Botox 117

Botulinum Toxin Compositions 117
Transport Protein, which is Used to Introduce Chemical
Compounds into Nerve Cells 117
Pharmaceutical Botulinum Toxin Compositions 118
Pharmaceutical Compositions Containing Botulinum Toxin 119
Skin Cosmesis Treatment with Clostridia Neurotoxins 119
Stable Liquid Formulations of Botulinum Toxin 119
PATENTS RELATING TO ENZYMES 120
Sample of Patents Relating to Enzymes 120
Treatment and Composition for Achieving Skin Antiaging
Benefits by Corneum Protease Activation 120
Herbal Composition for the Prevention of Wrinkles and Skin
Disorders, Methods of Preparing the Same and Uses Thereof 121
Anti-wrinkle Agent 121
Process for Treating the Skin Comprising Applying to the Skin at
Least One Composition Comprising at Least One
N-aminoacylamide
122
Activator Including Biosurfactant as Active Ingredient, Mannosyl
Erythritol Lipid, and Production Method Thereof 123
PATENTS RELATING TO MOISTURIZERS 123

Sample of Patents Relating to Moisturizers 123
Cosmetic or Dermatological Stick 123
Topical Composition, Topical Composition Precursor, and
Methods for Manufacturing and Using 124
Cosmetic 124
Microalgae-derived Compositions for Improving the Health and
Appearance of Skin 125
Personal Care Compositions that Deposit Hydrophilic Benefit
Agents 125
Use of an Extract of the Orchid Vanda coerulea as a Skin
Hydrating Agent 126
Urea Compounds that Promote Desquamation 126
Sulfamide Derivatives and Cosmetic Use Thereof 127
PATENTS RELATING TO PEPTIDES 127
Sample of Patents Relating to Peptides 127
Synthetic Peptides for Use as Inhibitors of Neurotransmitter
Secretion and as Inducers of Cellular Relaxation 127
Osmoprotective Complexes for Prevention of Intracellular
Dehydration in Mammals 128
Compositions and Methods of Their Use for Improving the
Condition and Appearance of Skin 129
Prevention of Cellular Senescence in Mammals by Natural
Peptide Complexes 129
Skin Care Compositions 130
Oligopeptides and Compositions Containing the Oligopeptides 130
Protective Skin Care Peptides 131
PATENTS RELATING TO RETINOIDS 131
Sample of Patents Relating to Retinoids 132
Photostabilization of Retinoids with Alkoxycrylene Compounds 132
Composition for Restoration of Age Related Tissue Loss in the
Face or Selected Areas of the Body 132
Oleaginous Pharmaceutical and Cosmetic Foam 133
PATENTS RELATING TO SUNSCREENS 133
Sample of Patents Relating to Sunscreens 133
Photostabilization of Coenzyme Q Compounds with

Alkoxycrylene Compounds 133
Stabilized Glycerin-in-oil Emulsions 134
Personal Care Compositions Having Improved Compatibility and
Providing Improved Sun Protection 134
Metal Oxide Composition 135
Dispersions of Inorganic Particulates Containing Alkoxycrylene 135
Powder Makeup Compositions and Methods 136
CHAPTER 8 COMPANY PROFILES 138
INTRODUCTION 138
MAJOR MANUFACTURERS OF COSMECEUTICALS 138
ALLERGAN, INC. 138
AVON PRODUCTS, INC. 138
BASF SE, COMPANY 139
BEIERSDORF AG 139
ELIZABETH ARDEN, INC. 140
ESTEE LAUDER COMPANIES, INC. 140
JOHNSON & JOHNSON 140
KAO CORPORATION 141
KOSE CORPORATION 141
L'OREAL SA 142
L'Oreal Paris USA 142
MEDICIS PHARMACEUTICAL CORPORATION 142

MERCK & COMPANY 143
PHYSICIANS FORMULA HOLDINGS, INC. 143
PROCTER & GAMBLE 143
REVLON WORLDWIDE CORP 144
ROYAL DSM NV 144
SHISEIDO CO., LTD 144
UNILEVER PLC 145
Unilever USA, Inc. 145
SELECT SPECIALTY BRANDS OF COSMECEUTICALS 146
AHAVA 146
Ahava North America 146
CLARINS USA 146
DERMALOGICA 147
GARNIER 147
JANE IREDALE (A.K.A. IREDALE MINERAL COSMETICS) 147
OBAGI MEDICAL PRODUCTS, INC. 148
ORIGINS 148
PCA SKIN (A.K.A. PHYSICIAN CARE ALLIANCE, LLC) 149
SKINCEUTICALS 149
STRIVECTIN 150

LIST OF TABLES

SUMMARY TABLE GLOBAL SALES OF TOPICAL AND INJECTABLE COSMECEUTICALS,
THROUGH 2017 ($ MILLIONS) 6
TABLE 1 BUSINESS PATTERN OF U.S. TOILET PREPARATION AND MANUFACTURING
INDUSTRY (NO./%) 16
TABLE 2 INGREDIENTS BANNED FROM COSMETICS SOLD IN THE U.S. 20
TABLE 3 EXAMPLES OF ACCEPTABLE AND UNACCEPTABLE CLAIMS FOR CONTOUR
CREAMS IN CANADA 28
TABLE 4 EXAMPLES OF ACCEPTABLE AND UNACCEPTABLE CLAIMS FOR EXFOLIANTS
IN CANADA 28
TABLE 5 EXAMPLES OF ACCEPTABLE AND UNACCEPTABLE CLAIMS FOR
MOISTURIZERS IN CANADA 29
TABLE 6 EXAMPLES OF ACCEPTABLE AND UNACCEPTABLE CLAIMS FOR VITAMINS,
MINERALS AND ANTIOXIDANTS IN CANADA 29
TABLE 7 REGULATIONS RELATING TO COSMETICS IN CHINA 36
TABLE 8 PRODUCT-SPECIFIC REGULATIONS IN AUSTRALIA 43
TABLE 9 EXAMPLES OF ANTIOXIDANTS USED IN COSMECEUTICALS 48
TABLE 10 TYPES OF ANTIBACTERIAL AGENTS USED IN COSMECEUTICALS 49
TABLE 11 EXAMPLES OF BOTANICALS USED IN COSMECEUTICALS 50
TABLE 12 EXAMPLES OF DEPIGMENTING AGENTS USED IN COSMECEUTICALS 51
TABLE 13 EXAMPLES OF ENZYMES USED IN COSMECEUTICALS 52
TABLE 14 EXAMPLES OF HYDROXY ACIDS USED IN COSMECEUTICALS 53
TABLE 15 EXAMPLES OF MOISTURIZERS USED IN COSMECEUTICALS 54
TABLE 16 TYPES OF PEPTIDES USED IN COSMECEUTICALS 55
TABLE 17 SAMPLE OF TOPICAL ANTIAGING COSMECEUTICALS 57
TABLE 18 SAMPLE OF TOPICAL DEPIGMENTING COSMECEUTICALS 58
TABLE 19 SAMPLE OF TOPICAL APPEARANCE-ENHANCING COSMECEUTICALS 58
TABLE 20 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM AHAVA 60
TABLE 21 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM CLARINS 60
TABLE 22 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM DERMALOGICA 61
TABLE 23 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM GARNIER 62
TABLE 24 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM JANE IREDALE 63
TABLE 25 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM OBAGI MEDICAL
PRODUCTS 64
TABLE 26 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM ORIGINS 64
TABLE 27 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM PCA SKIN CARE 65
TABLE 28 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM SKINCEUTICALS 66
TABLE 29 EXAMPLES OF SPECIALTY COSMECEUTICALS FROM STRIVECTIN 67
TABLE 30 GLOBAL SALES OF TOPICAL COSMECEUTICALS BY PRODUCT FUNCTION,
2011 ($ MILLIONS, %) 68
TABLE 31 ADDITION MAJOR MANUFACTURERS OF TOPICAL COSMECEUTICALS 71
TABLE 32 MANUFACTURERS OF SPECIALTY TOPICAL COSMECEUTICALS 71
TABLE 33 GLOBAL SALES OF TOPICAL COSMECEUTICALS BY PRODUCT FUNCTION,
THROUGH 2017 ($ MILLIONS) 76
TABLE 34 GLOBAL SALES OF TOPICAL COSMECEUTICALS BY REGION, THROUGH
2017 ($ MILLIONS) 78
TABLE 35 GLOBAL SALES OF ANTIAGING TOPICAL COSMECEUTICALS BY REGION,
THROUGH 2017 ($ MILLIONS) 79
TABLE 36 GLOBAL SALES OF APPEARANCE-ENHANCING TOPICAL COSMECEUTICALS
BY REGION, THROUGH 2017 ($ MILLIONS) 81
TABLE 37 U.S. FDA-APPROVED BOTULINUM TOXIN FOR COSMETIC USE 85
TABLE 38 GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY TYPE, 2011 ($
MILLIONS/%) 90
TABLE 39 MAJOR MANUFACTURERS OF INJECTABLE COSMECEUTICALS 93
TABLE 40 GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY TYPE, THROUGH
2017 ($ MILLIONS) 95
TABLE 41 GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY REGION, THROUGH
2017 ($ MILLIONS) 96
TABLE 42 GLOBAL SALES OF BOTOX-TYPE COSMETICS BY REGION, THROUGH 2017
($ MILLIONS) 98
TABLE 43 GLOBAL SALES OF DERMAL FILLERS BY REGION, THROUGH 2017 ($
MILLIONS) 99
TABLE 44 U.S. PATENTS AWARDED FOR COSMECEUTICAL INGREDIENTS BY TYPE,
2011–2012 (NO./%) 105
TABLE 45 U.S. PATENTS AWARDED FOR COSMECEUTICAL INGREDIENTS BY REGION,
2011–2012 (NO./%) 106

LIST OF FIGURES

SUMMARY FIGURE PROJECTED SHARES OF GLOBAL COSMECEUTICAL SALES BY TYPE,
2012 AND 2017 (%) 6
FIGURE 1 ESTIMATED MARKET SHARES OF GLOBAL SALES OF TOPICAL
COSMECEUTICALS BY PRODUCT FUNCTION, 2011 (%) 69
FIGURE 2 ESTIMATED MARKET SHARES OF GLOBAL SALES OF TOPICAL
COSMECEUTICALS BY REGION, 2011 (%) 70
FIGURE 3 ESTIMATED SHARES OF GLOBAL TOPICAL COSMECEUTICAL SALES BY
PRODUCT FUNCTION, 2012 AND 2017 (%) 76
FIGURE 4 ESTIMATED SHARES OF GLOBAL TOPICAL COSMECEUTICAL SALES BY
REGION, 2012 AND 2017 (%) 78
FIGURE 5 ESTIMATED SHARES OF GLOBAL ANTIAGING TOPICAL COSMECEUTICAL
SALES BY REGION, 2012 AND 2017 (%) 80
FIGURE 6 ESTIMATED SHARES OF GLOBAL APPEARANCE TOPICAL COSMECEUTICAL
SALES BY REGION, 2012 AND 2017 (%) 81
FIGURE 7 GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY TYPE, 2011 (%) 91
FIGURE 8 ESTIMATED MARKET SHARES OF GLOBAL SALES OF INJECTABLE
COSMECEUTICALS BY REGION, 2011 (%) 92
FIGURE 9 ESTIMATED SHARES OF GLOBAL INJECTABLE COSMECEUTICAL SALES BY
TYPE, 2012 AND 2017 (%) 95
FIGURE 10 ESTIMATED SHARES OF GLOBAL INJECTABLE COSMECEUTICAL SALES BY
REGION, 2012 AND 2017 (%) 96
FIGURE 11 ESTIMATED SHARES OF GLOBAL BOTOX-TYPE COSMETIC SALES BY
REGION, 2012 AND 2017 (%) 98
FIGURE 12 ESTIMATED SHASALES BY REGION, 2012 AND 2017 (%) 81
FIGURE 7 GLOBAL SALES OF INJECTABLE COSMECEUTICALS BY TYPE, 2011 (%) 91
FIGURE 8 ESTIMATED MARKET SHARES OF GLOBAL SALES OF INJECTABLE
COSMECEUTICALS BY REGION, 2011 (%) 92
FIGURE 9 ESTIMATED SHARES OF GLOBAL INJECTABLE COSMECEUTICAL SALES BY
TYPE, 2012 AND 2017 (%) 95
FIGURE 10 ESTIMATED SHARES OF GLOBAL INJECTABLE COSMECEUTICAL SALES BY
REGION, 2012 AND 2017 (%) 96
FIGURE 11 ESTIMATED SHARES OF GLOBAL BOTOX-TYPE COSMETIC SALES BY
REGION, 2012 AND 2017 (%) 98
FIGURE 12 ESTIMATED SHARES

To order this report:
Biomaterial Industry: Cosmeceuticals: Products and Global Markets

__________________________
Contact Clare: clare@reportlinker.com  
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker